AstraZeneca Bets Big on China: $700M Innovation Hub in Qingdao 
AstraZeneca’s $700M Qingdao investment fuels China’s rise as a global innovation leader, with a focus on breakthrough inhaled medicines. 
QingdaoDev
NewspaperAmigo – Your Global News Buddy 
Timely Reports, Friendly Voices – Your Daily News Amigo